Man Group PLC Royalty Pharma PLC Transaction History

Man Group PLC

$54.1 Billion
Q3 2025

A detailed history of Man Group PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Man Group PLC holds 187,082 shares of RPRX stock, worth $7.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

187,082

Previous 14,238 1213.96%

Holding current value

$7.33 Million

Previous $512,000 1189.06%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$34.9 - $37.91 $6.03 Million - $6.55 Million	172,844 Added 1213.96%	187,082 $6.6 Million
Q2 2025 Aug 14, 2025	SELL	$30.85 - $36.14 $2 Million - $2.34 Million	-64,673 Reduced 81.96%	14,238 $512,000
Q1 2025 May 15, 2025	SELL	$25.75 - $33.86 $19 Million - $24.9 Million	-736,516 Reduced 90.32%	78,911 $2.46 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $10.5 Million - $12.3 Million	433,245 Added 113.36%	815,427 $20.8 Million
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $16.1 Million - $18.4 Million	-628,286 Reduced 62.18%	382,182 $10.8 Million

Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $21.4 Million - $24.3 Million	813,343 Added 412.6%	1,010,468 $26.6 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $65.4 Million - $74.6 Million	-2,382,027 Reduced 92.36%	197,125 $5.99 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $37.9 Million - $42.2 Million	1,445,537 Added 127.52%	2,579,152 $72.4 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $14.6 Million - $17.4 Million	555,562 Added 96.11%	1,133,615 $30.8 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $8.07 Million - $9.96 Million	272,545 Added 89.21%	578,053 $17.8 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $525,958 - $632,370	-16,050 Reduced 4.99%	305,508 $11 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $723,274 - $813,198	18,465 Added 6.09%	321,558 $12.7 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $2.52 Million - $2.82 Million	-63,110 Reduced 17.23%	303,093 $12.2 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $7.13 Million - $8.41 Million	190,088 Added 107.93%	366,203 $15.4 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $5.07 Million - $5.74 Million	135,259 Added 331.06%	176,115 $6.86 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $1.44 Million - $1.74 Million	40,856 New	40,856 $1.63 Million
Q2 2021 Aug 16, 2021	SELL	$39.85 - $46.63 $965,645 - $1.13 Million	-24,232 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $1.03 Million - $1.28 Million	24,232 New	24,232 $1.06 Million
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $1.34 Million - $1.85 Million	-37,062 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $1.43 Million - $1.79 Million	37,062 New	37,062 $1.56 Million

Others Institutions Holding RPRX

# of Institutions

535

Shares Held

303M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account